News
AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation it will shift its ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...
AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S ...
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
For the FTSE 100 it was a day where things only got better as the day went on, with the bluechip benchmark closing at yet ...
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. Revenue in its oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback